• SENSEX

    {{sensexData[0].price}} (+{{sensexData[0].change}}%)

  • SENSEX

    {{sensexData[0].price}} ({{sensexData[0].change}}%)

  • NIFTY 50

    {{niftyData[0].open_price}} (+{{niftyData[0].change}}%)

  • NIFTY 50

    {{niftyData[0].open_price}} ({{niftyData[0].change}}%)

  • {{mcxData[2].symbol}}

    {{mcxData[2].price}} (+{{mcxData[2].PerChange}}%)

  • {{mcxData[2].symbol}}

    {{mcxData[2].price}} ({{mcxData[2].PerChange}}%)

  • {{mcxData[0].symbol}}

    {{mcxData[0].price}} (+{{mcxData[0].PerChange}}%)

  • {{mcxData[0].symbol}}

    {{mcxData[0].price}} ({{mcxData[0].PerChange}}%)

  • {{mcxData[1].symbol}}

    {{mcxData[1].price}} (+{{mcxData[1].PerChange}}%)

  • {{mcxData[1].symbol}}

    {{mcxData[1].price}} ({{mcxData[1].PerChange}}%)

  • {{mcxData[3].symbol}}

    {{mcxData[3].price}} (+{{mcxData[3].PerChange}}%)

  • {{mcxData[3].symbol}}

    {{mcxData[3].price}} ({{mcxData[3].PerChange}}%)

KIMS Hospitals expands into Kerala; plans to establish 3000 beds over next 5 years 
(17:10, 06 Nov 2024)

The company intends to develop new medical facilities and acquire 3000 beds in the state over the next five years in Kerala.

KIMS Hospitals, currently has presence in the 5 states of Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka with over 16 hospitals and 5000 plus beds.

In a regulatory filing made post market hours today, the company stated that it has already begun operations in Kerala by taking over Sreechand Hospital in Kannur and entering into an O&M contract with Westfort Hospital at Thrissur, where further development work is underway.

Over the next two years, the group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode, each with 800-bed capacities.

The group's expansion blueprint includes setting up a fully equipped oncology and transplant centre in Kannur, along with a 350-bed hospital in Thrissur dedicated to advanced transplant services.

In future plans, KIMS intends to acquire hospitals in Calicut and Trivandrum. In the distant future, it plans to explore possibility of opening one hospital in all districts of Kerala. All our units will mostly be asset light model.

Dr Bhaskar Rao, chairman and manging director, KIMS Hospitals said: 'Our sole aim is to bring accessible and affordable clinical healthcare services with world-class amenities to the people of Kerala and ensure that no patient in need is deprived of treatment due to financial constraints.

Headquartered in Hyderabad, Krishna Institute of Medical Sciences Limited (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost.

The hospital chain operator had reported 7.18% increase in consolidated net profit to ₹ 86.6 crore in Q1 FY25 from ₹ 80.8 crore posted in Q1 FY24. Revenue from operations rose by 13.6% year on year (YoY) to ₹ 688.4 crore during the quarter ended June 2024.

The scrip had gained 0.49% to end at ₹ 559.30 on the BSE today.

Powered by Capital Market - Live News

No Details of this news available

Mandatory Dematerialization for Transfer of Securities, w.e.f 5th December 2018. Refer to SEBI notification number SEBI/LAD-NRO/GN/2018/24 dated June 08,2018.

Update/Link your Aadhaar Number with your Demat Account by Submitting a photocopy of Aadhaar card along with a request letter/Modification form.

Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment.

Prevent Unauthorized Transactions in your demat account. Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day....... Issued in the interest of investors.

Prevent unauthorized transactions in your trading account ->Update your mobile numbers/email IDs with your stock brokers. Receive information/alerts of your transactions directly from Exchange on your mobile/email at the end of the day.... Issued in the interest of investors.

Filing Complaints on SCORES - Easy & quick.
a. Register on SCORES portal,
b. Provide mandatory details for filing complaints on SCORES like name, PAN, address, mobile number, email ID.
c. Benefits:
   i. Effective communication
   ii. Speedy redressal of the grievances

Investor Awareness regarding the revised guidelines on margin collection

 

Dear Investor,

As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.

https://www.bseipf.com/investors_education.html

We believe that an educated investor is a protected investor !!!

 

Risk Disclosure on Derivatives

  • out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:
SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.